Growth Metrics

INVO Fertility (IVF) Receivables (2010 - 2025)

INVO Fertility (IVF) reported Receivables of $43500.0 for Q3 2025, down 83.08% year-over-year from $257051.0 in Q3 2024, and up 16.0% on a QoQ basis from $37500.0 in Q2 2025.

INVO Fertility (IVF) has 16 years of Receivables data on file, last reported at $43500.0 in Q3 2025.

  • Quarterly Receivables fell 83.08% year-over-year to $43500.0 in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $43500.0 (down 83.08% YoY) and the FY2024 annual result came in at $22500.0, down 28.57% from the prior year.
  • Receivables grew to $43500.0 in Q3 2025 per IVF's latest filing, from $37500.0 in the prior quarter.
  • Across five years, Receivables topped out at $807811.0 in Q1 2021 and bottomed at $21600.0 in Q2 2022.
  • The 5-year median for Receivables is $71311.0 (2022), against an average of $128299.8.
  • The widest annual swing landed in 2021, when Receivables soared 21738.63%; it then slumped 92.73% in 2022.
  • Tracing IVF's Receivables over 5 years: stood at $50470.0 in 2021, then soared by 52.86% to $77149.0 in 2022, then surged by 82.18% to $140550.0 in 2023, then plunged by 83.99% to $22500.0 in 2024, then soared by 93.33% to $43500.0 in 2025.
  • Per Business Quant, the three latest IVF Receivables figures stand at $43500.0 (Q3 2025), $37500.0 (Q2 2025), and $25500.0 (Q1 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Receivables (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 8.21 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 3.57 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 6.36 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 3.15 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 973.00 Mn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 3.82 Bn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 1.11 Bn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 4.50 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 1.09 Bn
10 INVO Fertility 5.12 Mn 4.76 Mn 629,345.00 43,500.00

Historic Data

Download Data 🔒
DateValue
Sep 30, 2025 43,500.00
Jun 30, 2025 37,500.00
Mar 31, 2025 25,500.00
Dec 31, 2024 22,500.00
Sep 30, 2024 257,051.00
Jun 30, 2024 257,210.00
Mar 31, 2024 176,888.00
Dec 31, 2023 140,550.00
Sep 30, 2023 116,781.00
Jun 30, 2023 74,908.00
Mar 31, 2023 99,720.00
Dec 31, 2022 77,149.00
Sep 30, 2022 71,311.00
Jun 30, 2022 21,600.00
Mar 31, 2022 58,720.00
Dec 31, 2021 50,470.00
Sep 30, 2021 50,659.00
Jun 30, 2021 47,869.00
Mar 31, 2021 807,811.00
Dec 31, 2020 21,699.00
Sep 30, 2020 3,699.00
Jun 30, 2020 71,199.00
Mar 31, 2020 3,699.00
Dec 31, 2019 7,558.00
Sep 30, 2019 27,021.00
Jun 30, 2019 240,214.00
Mar 31, 2019 74,717.00
Dec 31, 2018 225,899.00
Sep 30, 2018 187,141.00
Jun 30, 2018 139,393.00
Mar 31, 2018 110,857.00
Dec 31, 2017 86,697.00
Sep 30, 2017 60,182.00
Jun 30, 2017 42,984.00
Mar 31, 2017 32,300.00
Dec 31, 2016 2,794.00
Sep 30, 2016 9,692.00
Jun 30, 2016 18,245.00
Mar 31, 2016 18,107.00
Dec 31, 2015 1,346.00
Sep 30, 2015 1,346.00
Jun 30, 2015 321.00
Mar 31, 2015 2,134.00
Dec 31, 2014 321.00
Sep 30, 2014 3,757.00
Jun 30, 2014 1,927.00
Mar 31, 2014 9,188.00
Dec 31, 2013 1,765.00
Sep 30, 2013 -485.00
Jun 30, 2013 1,627.00
Mar 31, 2013 3,977.00
Dec 31, 2012 12,460.00
Sep 30, 2012 4,628.00
Jun 30, 2012 6,898.00
Mar 31, 2012 10,681.00
Dec 31, 2011 5,577.00
Sep 30, 2011 9,415.00
Jun 30, 2011 13,935.00
Dec 31, 2010 15,706.00